Functional validation experiments in two T-ALL cell lines demonstrated that mutated IL7R signaling molecules robustly activate the downstream molecules AKT and MEK-ERK, thereby inducing steroid resistance. The gene discussed is IL7R; the disease is acute lymphoblastic leukemia.